CIK 0000874015 · Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 330336973
- Phone
- 7609319200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-15 | Kordasiewicz Holly B. EVP, Chief Development Officer | Grant or award · Restricted Stock Unit | +13,650 | 34,480 | ||
| 2026-01-15 | Kordasiewicz Holly B. EVP, Chief Development Officer | Grant or award · Restricted Stock Unit | +11,250 | 45,730 | ||
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise | +7,013 | 18,212 | ||
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Performance Restricted Stock Units | +25,800 | 44,500 | ||
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Grant or award · Restricted Stock Unit | +9,675 | 37,725 | ||
| 2026-01-15 | Jenne Kyle EVP, Chf GL Pdt Str Ofcr | Option exercise · Restricted Stock Unit | −7,013 | 29,664 | ||
| 2026-01-15 | HOUGEN ELIZABETH L EVP, Finance & CFO | Option exercise | +28,729 | 139,229 | ||
| 2026-01-15 | HOUGEN ELIZABETH L EVP, Finance & CFO | Grant or award · Performance Restricted Stock Units | +34,360 | 120,995 | ||
| 2026-01-15 | HOUGEN ELIZABETH L EVP, Finance & CFO | Option exercise · Restricted Stock Unit | −28,729 | 55,940 | ||
| 2026-01-15 | HOUGEN ELIZABETH L EVP, Finance & CFO | Grant or award · Restricted Stock Unit | +12,885 | 68,825 | ||
| 2026-01-15 | Devers Shannon L. EVP, Chief Human Resources Ofc | Option exercise | +17,377 | 34,871 | ||
| 2026-01-15 | Devers Shannon L. EVP, Chief Human Resources Ofc | Grant or award · Performance Restricted Stock Units | +25,800 | 47,800 | ||
| 2026-01-15 | Devers Shannon L. EVP, Chief Human Resources Ofc | Option exercise · Restricted Stock Unit | −17,377 | 43,029 | ||
| 2026-01-15 | Devers Shannon L. EVP, Chief Human Resources Ofc | Grant or award · Restricted Stock Unit | +9,675 | 52,704 | ||
| 2026-01-15 | Birchler Brian EVP, Corp and Development Ops | Option exercise | +20,089 | 68,915 | ||
| 2026-01-15 | Birchler Brian EVP, Corp and Development Ops | Grant or award · Performance Restricted Stock Units | +25,800 | 79,138 | ||
| 2026-01-15 | Birchler Brian EVP, Corp and Development Ops | Option exercise · Restricted Stock Unit | −20,089 | 41,126 | ||
| 2026-01-15 | Birchler Brian EVP, Corp and Development Ops | Grant or award · Restricted Stock Unit | +9,675 | 50,801 | ||
| 2026-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Option exercise | +21,055 | 103,734 | ||
| 2026-01-15 | BENNETT C FRANK EVP, Chief Scientific Officer | Grant or award · Performance Restricted Stock Units | +25,800 | 89,282 |
Page 15 of 18 · 360 trades